365 related articles for article (PubMed ID: 28102838)
1. Autophagy dysregulation in Danon disease.
Nascimbeni AC; Fanin M; Angelini C; Sandri M
Cell Death Dis; 2017 Jan; 8(1):e2565. PubMed ID: 28102838
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle.
Malicdan MC; Noguchi S; Nonaka I; Saftig P; Nishino I
Neuromuscul Disord; 2008 Jul; 18(7):521-9. PubMed ID: 18502640
[TBL] [Abstract][Full Text] [Related]
3. LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease.
Rothaug M; Stroobants S; Schweizer M; Peters J; Zunke F; Allerding M; D'Hooge R; Saftig P; Blanz J
Acta Neuropathol Commun; 2015 Jan; 3():6. PubMed ID: 25637286
[TBL] [Abstract][Full Text] [Related]
4. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.
Arhzaouy K; Papadopoulos C; Schulze N; Pittman SK; Meyer H; Weihl CC
Autophagy; 2019 Jun; 15(6):1082-1099. PubMed ID: 30654731
[TBL] [Abstract][Full Text] [Related]
5. LAMP-2B regulates human cardiomyocyte function by mediating autophagosome-lysosome fusion.
Chi C; Leonard A; Knight WE; Beussman KM; Zhao Y; Cao Y; Londono P; Aune E; Trembley MA; Small EM; Jeong MY; Walker LA; Xu H; Sniadecki NJ; Taylor MR; Buttrick PM; Song K
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):556-565. PubMed ID: 30584088
[TBL] [Abstract][Full Text] [Related]
6. Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease.
Nemazanyy I; Blaauw B; Paolini C; Caillaud C; Protasi F; Mueller A; Proikas-Cezanne T; Russell RC; Guan KL; Nishino I; Sandri M; Pende M; Panasyuk G
EMBO Mol Med; 2013 Jun; 5(6):870-90. PubMed ID: 23630012
[TBL] [Abstract][Full Text] [Related]
7. Cross-regulation of defective endolysosome trafficking and enhanced autophagy through TFEB in UNC13D deficiency.
Zhang J; He J; Johnson JL; Napolitano G; Ramadass M; Rahman F; Catz SD
Autophagy; 2019 Oct; 15(10):1738-1756. PubMed ID: 30892133
[TBL] [Abstract][Full Text] [Related]
8. A family with Danon disease caused by a splice site mutation in LAMP2 that generates a truncated protein.
Zhou N; Cui J; Zhao W; Jiang Y; Zhu W; Tang L; Li X; Sun M; Pan C; Shu X
Mol Genet Genomic Med; 2019 Mar; 7(3):e561. PubMed ID: 30714332
[TBL] [Abstract][Full Text] [Related]
9. Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Tousley A; Valentine DT; Sapp E; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Oct; 5(3):249-260. PubMed ID: 27689619
[TBL] [Abstract][Full Text] [Related]
10. Danon disease: a phenotypic expression of LAMP-2 deficiency.
Endo Y; Furuta A; Nishino I
Acta Neuropathol; 2015 Mar; 129(3):391-8. PubMed ID: 25589223
[TBL] [Abstract][Full Text] [Related]
11. YY1 cooperates with TFEB to regulate autophagy and lysosomal biogenesis in melanoma.
Du J; Ren W; Yao F; Wang H; Zhang K; Luo M; Shang Y; O'Connell D; Bei Z; Wang H; Xiong R; Yang Y
Mol Carcinog; 2019 Nov; 58(11):2149-2160. PubMed ID: 31448838
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease.
Spampanato C; Feeney E; Li L; Cardone M; Lim JA; Annunziata F; Zare H; Polishchuk R; Puertollano R; Parenti G; Ballabio A; Raben N
EMBO Mol Med; 2013 May; 5(5):691-706. PubMed ID: 23606558
[TBL] [Abstract][Full Text] [Related]
13. Autophagy in lysosomal myopathies.
Malicdan MC; Nishino I
Brain Pathol; 2012 Jan; 22(1):82-8. PubMed ID: 22150923
[TBL] [Abstract][Full Text] [Related]
14. What else is in store for autophagy? Exocytosis of autolysosomes as a mechanism of TFEB-mediated cellular clearance in Pompe disease.
Feeney EJ; Spampanato C; Puertollano R; Ballabio A; Parenti G; Raben N
Autophagy; 2013 Jul; 9(7):1117-8. PubMed ID: 23669057
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor.
Ng KM; Mok PY; Butler AW; Ho JC; Choi SW; Lee YK; Lai WH; Au KW; Lau YM; Wong LY; Esteban MA; Siu CW; Sham PC; Colman A; Tse HF
Circulation; 2016 Nov; 134(18):1373-1389. PubMed ID: 27678261
[TBL] [Abstract][Full Text] [Related]
16. Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients.
Nascimbeni AC; Fanin M; Masiero E; Angelini C; Sandri M
Autophagy; 2012 Nov; 8(11):1697-700. PubMed ID: 22940840
[TBL] [Abstract][Full Text] [Related]
17. Critical Role of TFEB-Mediated Lysosomal Biogenesis in Alcohol-Induced Pancreatitis in Mice and Humans.
Wang S; Ni HM; Chao X; Ma X; Kolodecik T; De Lisle R; Ballabio A; Pacher P; Ding WX
Cell Mol Gastroenterol Hepatol; 2020; 10(1):59-81. PubMed ID: 31987928
[TBL] [Abstract][Full Text] [Related]
18. Melatonin antagonizes cadmium-induced neurotoxicity by activating the transcription factor EB-dependent autophagy-lysosome machinery in mouse neuroblastoma cells.
Li M; Pi H; Yang Z; Reiter RJ; Xu S; Chen X; Chen C; Zhang L; Yang M; Li Y; Guo P; Li G; Tu M; Tian L; Xie J; He M; Lu Y; Zhong M; Zhang Y; Yu Z; Zhou Z
J Pineal Res; 2016 Oct; 61(3):353-69. PubMed ID: 27396692
[TBL] [Abstract][Full Text] [Related]
19. Autophagic vacuolar myopathy.
Nishino I
Semin Pediatr Neurol; 2006 Jun; 13(2):90-5. PubMed ID: 17027858
[TBL] [Abstract][Full Text] [Related]
20. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.
Zhitomirsky B; Yunaev A; Kreiserman R; Kaplan A; Stark M; Assaraf YG
Cell Death Dis; 2018 Dec; 9(12):1191. PubMed ID: 30546014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
